What would be the most appropriate α/β ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer

BioMed Research International
Alexander ChiRitsuko Komaki

Abstract

We hypothesize that the correlation between the radiation dose expressed as the biologically effective dose (BED) and the clinical endpoints will correlate better as the value of the α/β ratio is increased to >10 Gy, which theoretically minimizes the overestimation of the dose potency associated with the linear quadratic (LQ) formula in the setting of stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC). A search was conducted in the PubMed electronic databases in August 2011. In the studies analyzed, increasing the α/β ratio is associated with an increase in the strength of the correlation between isocenter BED and local control, especially in the studies with median followup of ≥24 months, for which Spearman's correlation coefficients of 0.74-0.76 were achieved for α/β of 20 Gy, 30 Gy, and 50 Gy (P =  0.007-0.008). A trend toward statistical significance was observed for the correlation of isocenter BED and the 2-year overall survival when an α/β of 20 Gy was used approached statistical significance (P = 0.073). Our results suggest that an α/β > 10 Gy may be more appropriate for the prediction of dose response in the setting of lung SBRT.

References

Mar 1, 1989·International Journal of Radiation Oncology, Biology, Physics·B MaciejewskiA Hliniak
Feb 8, 2000·International Journal of Radiation Oncology, Biology, Physics·J F Fowler, R Chappell
Apr 16, 2003·International Journal of Radiation Oncology, Biology, Physics·Rikiya OnimaruHirotoshi Dosaka-Akita
Nov 30, 2004·Physics in Medicine and Biology·M Guerrero, X Allen Li
Oct 8, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Joern WulfMichael P Flentje
Oct 11, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jan NymanUlla Hultén
Jun 13, 2006·International Journal of Radiation Oncology, Biology, Physics·Tingyi XiaJoe Y Chang
Jul 19, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Hiroshi OnishiTsutomu Araki
Nov 21, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Masashi KotoShogo Yamada
Jan 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Frank J LagerwaardS Senan
Feb 12, 2008·International Journal of Radiation Oncology, Biology, Physics·Clint ParkRobert D Timmerman
Mar 13, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Alice W Y NgVicty Y W Wong
Nov 4, 2008·International Journal of Radiation Oncology, Biology, Physics·Matthias GuckenbergerMichael Flentje
Nov 19, 2008·International Journal of Radiation Oncology, Biology, Physics·Jack F Fowler
Mar 3, 2009·International Journal of Radiation Oncology, Biology, Physics·Achilles J FakirisRobert Timmerman
Mar 20, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Noëlle C van der Voort van ZypJoost J Nuyttens
May 6, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pia BaumannRolf Lewensohn
Jun 27, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Umberto RicardiRiccardo Ragona
Jun 30, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Neil KopekMorten Høyer
Jul 28, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kevin L StephansGregory M M Videtic
Jan 16, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Alexander ChiRitsuko Komaki
Mar 18, 2010·JAMA : the Journal of the American Medical Association·Robert TimmermanHak Choy
Apr 20, 2010·The Journal of Thoracic and Cardiovascular Surgery·Traves D CrabtreeJeffrey D Bradley
May 18, 2010·International Journal of Radiation Oncology, Biology, Physics·Yukinori MatsuoMasahiro Hiraoka
Jul 7, 2010·The British Journal of Radiology·J F Fowler
Jul 20, 2010·International Journal of Radiation Oncology, Biology, Physics·Hiroshi OnishiTsutomu Araki
Aug 17, 2010·International Journal of Radiation Oncology, Biology, Physics·Samuel BralGuy Storme
Mar 4, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·X Sharon QiX Allen Li
Apr 5, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Mike PartridgeMichael Brada
Jul 5, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Nicolaus AndratschkeHans Geinitz
Apr 24, 2013·International Journal of Radiation Oncology, Biology, Physics·Chang W SongSeymour H Levitt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.